Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 — For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) versus dipeptidyl peptidase-4 inhibitors…
GLP-1 receptor agonists may improve outcomes in idiopathic intracranial hypertension
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional therapies, according to a study published online July 14 in JAMA Neurology.
Muscle loss from GLP-1 drugs could undermine long-term health
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health, University of Virginia experts warn in a new paper.
GLP-1 drugs fail to provide key long-term health benefit, study shows
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health, University of Virginia experts warn in a new paper.
GLP-1 Weight Loss Drugs May Undermine Muscle, Heart Health
Post Content
Higher BMI, Bigger Gains: Tirzepatide’s Effects on HFpEF
Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat distribution, with greater weight loss linked to better outcomes, a study finds. Medscape Medical News
Malnutrition with use of GLP-1 agonists is an underestimated real world harm
Food insecurity is increasing, particularly in the UK and for the most deprived groups of people.1 Suppressing appetite by using new glucagon-like peptide-1 (GLP-1) receptor agonists such as tirzepatide and semaglutide in people with nutritionally poor diets could lead to serious and likely underestimated nutritional complications. Evidence shows that the use of GLP-1 agonists is […]
No, there’s no such thing as ‘natural Ozempic’
GLP-1 receptor agonist drugs like Ozempic help people manage type 2 diabetes. Foods like Greek yogurt and avocados can’t do that, writes columnist Carrie Dennett.